Clinical trial
Circulating Tumor DNA in Stage I, II, and III Germ-Cell Tumors
NCT07401316 is registered in ClinicalTrials.gov with Indiana University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Circulating Tumor DNA in Stage I, II, and III Germ-Cell Tumors
- Lead sponsor
- Indiana University
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- June 3, 2026
- Completion date
- December 31, 2032
- Enrollment
- 130 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
germ cell cancer metastatic